metricas
covid
Buscar en
Medicina Clínica
Toda la web
Inicio Medicina Clínica Vitiligo as durvalumab's immune-related adverse event in lung cancer
Journal Information

Statistics

Follow this link to access the full text of the article

Scientific letter
Vitiligo as durvalumab's immune-related adverse event in lung cancer
Vitíligo como evento adverso inmunomediado secundario a durvalumab en cáncer de pulmón
Jacobo Rogadoa,d,
Corresponding author
jacobo.rogado@gmail.com

Corresponding author.
, Diego Buendía-Castañob,d, Soledad R. Alonso-Garcíac,d
a Medical Oncology Department, Hospital Universitario Infanta Leonor, Gran vía del este, 80, 28031 Madrid, Spain
b Dermatology Department, Hospital Universitario Infanta Leonor, Gran vía del este, 80, 28031 Madrid, Spain
c Pathology Department, Hospital Universitario Infanta Leonor, Gran vía del este, 80, 28031 Madrid, Spain
d Universidad Complutense de Madrid, Madrid, Spain
Read
13
Times
was read the article
7
Total PDF
6
Total HTML
Share statistics
Article information
ISSN: 00257753
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2023 March 1 3 4
2022 July 2 2 4
2022 May 1 0 1
2022 April 2 2 4

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos